Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Ordinary Shares, nominal value of $0.01 per share
-
Shares outstanding
-
2,461,355,158
-
Number of holders
-
11
-
Total 13F shares, excl. options
-
243,277
-
Shares change
-
+53,465
-
Total reported value, excl. options
-
$990,304
-
Value change
-
+$226,732
-
Number of buys
-
6
-
Number of sells
-
3
-
Price
-
$4.07
Institutional Holders of Sofgen Pharma S.A. - Ordinary Shares, nominal value of $0.01 per share (PROCF) as of Q4 2023
As of 31 Dec 2023 Sofgen Pharma S.A. - Ordinary Shares, nominal value of $0.01 per share (PROCF) had 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 243,277 shares of stock of the company.
Largest 10 holders included Exome Asset Management LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, UBS Group AG, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, Activest Wealth Management, JPMORGAN CHASE & CO, Pineridge Advisors LLC, ROYAL BANK OF CANADA, and MORGAN STANLEY.
This table shows 14 institutional shareholders of the security as of 31 Dec 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.